{"Symbol": "ABPWW", "AssetType": "Common Stock", "Name": "Abpro Holdings Inc", "Description": "Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. The company is headquartered in Woburn, Massachusetts.", "CIK": "1893219", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "", "Industry": "", "Address": "68 CUMMINGS PARK DRIVE, WOBURN, MA, UNITED STATES, 01801", "OfficialSite": "https://abpro.co", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "None", "EBITDA": "-9301000", "PERatio": "None", "PEGRatio": "None", "BookValue": "-6.04", "DividendPerShare": "None", "DividendYield": "None", "EPS": "None", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-2.296", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "1516000", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "6.32", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "-", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "-0.004", "52WeekHigh": "0.0874", "52WeekLow": "0.0116", "50DayMovingAverage": "0", "200DayMovingAverage": "0", "SharesOutstanding": "0", "SharesFloat": "1726800", "PercentInsiders": "0.000", "PercentInstitutions": "0.000", "DividendDate": "None", "ExDividendDate": "None"}